Cargando…
Correction to: Efficacy and safety of tetramethylpyrazine phosphate on pulmonary hypertension: study protocol for a randomized controlled study
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7104479/ https://www.ncbi.nlm.nih.gov/pubmed/32228673 http://dx.doi.org/10.1186/s13063-020-04245-x |
_version_ | 1783512242819432448 |
---|---|
author | Chen, Yuqin He, Wenjun Ouyang, Haiping Liu, Chunli Hong, Cheng Wang, Tao Yang, Kai Lu, Wenju Wang, Jian |
author_facet | Chen, Yuqin He, Wenjun Ouyang, Haiping Liu, Chunli Hong, Cheng Wang, Tao Yang, Kai Lu, Wenju Wang, Jian |
author_sort | Chen, Yuqin |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7104479 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-71044792020-03-31 Correction to: Efficacy and safety of tetramethylpyrazine phosphate on pulmonary hypertension: study protocol for a randomized controlled study Chen, Yuqin He, Wenjun Ouyang, Haiping Liu, Chunli Hong, Cheng Wang, Tao Yang, Kai Lu, Wenju Wang, Jian Trials Correction BioMed Central 2020-03-30 /pmc/articles/PMC7104479/ /pubmed/32228673 http://dx.doi.org/10.1186/s13063-020-04245-x Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Correction Chen, Yuqin He, Wenjun Ouyang, Haiping Liu, Chunli Hong, Cheng Wang, Tao Yang, Kai Lu, Wenju Wang, Jian Correction to: Efficacy and safety of tetramethylpyrazine phosphate on pulmonary hypertension: study protocol for a randomized controlled study |
title | Correction to: Efficacy and safety of tetramethylpyrazine phosphate on pulmonary hypertension: study protocol for a randomized controlled study |
title_full | Correction to: Efficacy and safety of tetramethylpyrazine phosphate on pulmonary hypertension: study protocol for a randomized controlled study |
title_fullStr | Correction to: Efficacy and safety of tetramethylpyrazine phosphate on pulmonary hypertension: study protocol for a randomized controlled study |
title_full_unstemmed | Correction to: Efficacy and safety of tetramethylpyrazine phosphate on pulmonary hypertension: study protocol for a randomized controlled study |
title_short | Correction to: Efficacy and safety of tetramethylpyrazine phosphate on pulmonary hypertension: study protocol for a randomized controlled study |
title_sort | correction to: efficacy and safety of tetramethylpyrazine phosphate on pulmonary hypertension: study protocol for a randomized controlled study |
topic | Correction |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7104479/ https://www.ncbi.nlm.nih.gov/pubmed/32228673 http://dx.doi.org/10.1186/s13063-020-04245-x |
work_keys_str_mv | AT chenyuqin correctiontoefficacyandsafetyoftetramethylpyrazinephosphateonpulmonaryhypertensionstudyprotocolforarandomizedcontrolledstudy AT hewenjun correctiontoefficacyandsafetyoftetramethylpyrazinephosphateonpulmonaryhypertensionstudyprotocolforarandomizedcontrolledstudy AT ouyanghaiping correctiontoefficacyandsafetyoftetramethylpyrazinephosphateonpulmonaryhypertensionstudyprotocolforarandomizedcontrolledstudy AT liuchunli correctiontoefficacyandsafetyoftetramethylpyrazinephosphateonpulmonaryhypertensionstudyprotocolforarandomizedcontrolledstudy AT hongcheng correctiontoefficacyandsafetyoftetramethylpyrazinephosphateonpulmonaryhypertensionstudyprotocolforarandomizedcontrolledstudy AT wangtao correctiontoefficacyandsafetyoftetramethylpyrazinephosphateonpulmonaryhypertensionstudyprotocolforarandomizedcontrolledstudy AT yangkai correctiontoefficacyandsafetyoftetramethylpyrazinephosphateonpulmonaryhypertensionstudyprotocolforarandomizedcontrolledstudy AT luwenju correctiontoefficacyandsafetyoftetramethylpyrazinephosphateonpulmonaryhypertensionstudyprotocolforarandomizedcontrolledstudy AT wangjian correctiontoefficacyandsafetyoftetramethylpyrazinephosphateonpulmonaryhypertensionstudyprotocolforarandomizedcontrolledstudy |